.jpg "Globus Medical (NYSE: GMED)")
Today it was reported that the President of Globus Medical (GMED), Anthony L. Williams, exercised options to sell 212,082 GMED shares at $27.68 a share, for a total transaction value of $9.93M.
In addition to Anthony L. Williams, one other GMED executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Globus Medical’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $196 million and quarterly net profit of $36.75 million. In comparison, last year the company earned revenue of $176 million and had a net profit of $24.38 million. GMED’s market cap is $4.51B and the company has a P/E ratio of 29.78. Currently, Globus Medical has an average volume of 462.1K.
Based on 8 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $55.00, reflecting a 20.0% upside.
The insider sentiment on Globus Medical has been negative according to 14 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology.
